Key Takeaways:
..The Senate voted 51-50 on August 7 to pass the Inflation Reduction Act.
..The legislation is expected to pass the House this week without changes and to be signed by President Biden.
..The...more
8/8/2022
/ Climate Change ,
Corporate Taxes ,
Drug Pricing ,
Energy Projects ,
Federal Funding ,
Inflation Adjustments ,
Medicare ,
Oil & Gas ,
Pending Legislation ,
Prescription Drugs ,
Renewable Energy ,
Superfund ,
Tax Credits
HEALTH PROVISIONS FACE UNCERTAINTY AS CONGRESS RETURNS FOR BUSY DECEMBER -
Lawmakers return to Washington this week after the Thanksgiving holiday with only 18 days before the government runs out of money – and that’s not...more
COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES -
House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the...more
DEMOCRATS PRESS FOR PRE-THANKSGIVING VOTE ON DRUG PRICING BILL -
The House Ways and Means Committee last week approved an amended version of legislation that would overhaul how Medicare and private insurers reimburse for...more
PELOSI INTRODUCES DRUG PRICING BILL WHILE TRUMP PUSHES SENATE VERSION -
House Democrats introduced legislation last week to lower prescription drug prices – including allowing Medicare to negotiate prices with...more
UPDATE ON DRUG PRICING LEGISLATION AS CONGRESS RECONVENES -
Congress reconvenes this week after a monthlong summer recess and begins what likely will be a final push toward overhauling prescription drug prices, but lack of...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
MAJOR HEALTH POLICY UNLIKELY IN POTENTIAL DEBT-SPENDING DEAL -
As House Speaker Nancy Pelosi, D-Calif., and...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
McCONNELL WANTS BIPARTISAN DEAL ON DRUG PRICES BY JULY -
To schedule time for debate in the Senate on...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
GRASSLEY CONFIRMS DELAY ON DRUG BILL WHILE ANOTHER COMMITTEE PLANS VOTES -
Senate Finance Committee Chairman...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more
6/11/2019
/ Data Breach ,
Data Protection ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicare ,
Medicare for All ,
Medicare Part D ,
Pharmaceutical Industry ,
Prescription Drugs ,
Prior Authorization
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Note that because Congress will be in recess for the Memorial Day holiday, the next “Capitol Hill Healthcare...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
HOUSE TO VOTE ON BILL COMBINING ACA, DRUG PRICING PROVISIONS -
The House is scheduled to vote on legislation...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
TRUMP, DEMOCRATIC LEADERS TO MEET ON DRUG PRICES -
During a White House meeting last week on infrastructure...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF -
Congress reconvenes today after a...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
HOUSE PANEL TO VOTE ON BIPARTISAN DRUG PRICING MEASURE -
The House Ways and Means Committee is scheduled to...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
REPUBLICANS BALK AT TRUMP’S CALL FOR NEW HEALTHCARE BILL -
President Donald Trump last week said Republicans...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS -
Outgoing FDA Commissioner Scott Gottlieb and...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices;...more
Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe...more
Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs.
The bill generally requires a...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more
2/5/2019
/ Affordable Care Act ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Medical Devices ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Pharmaceutical Industry ,
Preexisting Conditions ,
Prescription Drugs ,
Trump Administration
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug...more